Middle East Exosomes Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Instruments, Services), By Workflow (Isolation Methods, Downstream Analysis), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033
Description
Middle East Exosomes Market Summary
The Middle East exosomes market size was estimated at USD 3.07 million in 2024 and is projected to reach USD 20.03 million by 2033, growing at a CAGR of 23.38% from 2025 to 2033. Exosomes, or Extracellular Vesicles (EVs), are single-membrane vesicles released by diverse cell types, and they are detected in multiple bodily fluids, including urine, plasma, saliva, breast milk, semen, cerebrospinal fluid (CSF), bronchial fluid, and amniotic fluid. These vesicles serve as carriers of proteins and genetic material, playing a critical role in intercellular communication and emerging as valuable tools in diagnostics and therapeutics.
Middle East Exosomes Market Report Segmentation
This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Middle East exosomes market report based on product & service, workflow, application, end use, and country:
The Middle East exosomes market size was estimated at USD 3.07 million in 2024 and is projected to reach USD 20.03 million by 2033, growing at a CAGR of 23.38% from 2025 to 2033. Exosomes, or Extracellular Vesicles (EVs), are single-membrane vesicles released by diverse cell types, and they are detected in multiple bodily fluids, including urine, plasma, saliva, breast milk, semen, cerebrospinal fluid (CSF), bronchial fluid, and amniotic fluid. These vesicles serve as carriers of proteins and genetic material, playing a critical role in intercellular communication and emerging as valuable tools in diagnostics and therapeutics.
Middle East Exosomes Market Report Segmentation
This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Middle East exosomes market report based on product & service, workflow, application, end use, and country:
- Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
- Kits & Reagents
- Instruments
- Services
- Workflow Outlook (Revenue, USD Million, 2021 - 2033)
- Isolation Methods
- Ultracentrifugation
- Immunocapture on beads
- Precipitation
- Filtration
- Others
- Downstream Analysis
- Cell surface marker analysis using flow cytometry
- Protein analysis using blotting & ELISA
- RNA analysis with NGS & PCR
- Proteomic analysis using mass spectroscopy
- Others
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Cancer
- Neurodegenerative Diseases
- Cardiovascular Diseases
- Infectious Diseases
- Others
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostics Centers
- Academic & Research Institutes
- Country Outlook (Revenue, USD Million, 2021 - 2033)
- Middle East
- Saudi Arabia
- UAE
- Kuwait
- Qatar
- Oman
Table of Contents
120 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.2.1. Product & Service Segment
- 1.2.2. Workflow Segment
- 1.2.3. Application Segment
- 1.2.4. End Use Segment
- 1.3. Information analysis
- 1.3.1. Market formulation & data visualization
- 1.4. Data validation & publishing
- 1.5. Information Procurement
- 1.5.1. Primary Research
- 1.6. Information or Data Analysis
- 1.7. Market Formulation & Validation
- 1.8. Market Model
- 1.9. Total Market: CAGR Calculation
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Insights Landscape
- Chapter 3. Exosomes Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Growing adoption of exosome-based applications in diagnostics and therapeutics
- 3.2.1.2. Increasing investment in biomedical and translational research
- 3.2.1.3. Rising demand for liquid biopsy and non-invasive diagnostic technologies
- 3.2.2. Market restraint analysis
- 3.2.2.1. Stringent regulations pertaining to approval
- 3.2.2.2. Challenges associated with implementation of exosome-based therapies
- 3.2.2.3. High manufacturing and purification costs
- 3.3. Middle East Exosomes Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.2. PESTEL Analysis
- Chapter 4. Middle East Exosomes Market: Product & Service Estimates & Trend Analysis
- 4.1. Product & Services Segment Dashboard
- 4.2. Middle East Exosomes Market Product & Service Movement Analysis
- 4.3. Middle East Exosomes Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
- 4.4. Kits & reagents
- 4.4.1. Kits & reagents market estimates and forecasts 2021 to 2033 (USD Million)
- 4.5. Instruments
- 4.5.1. Instruments market estimates and forecasts 2021 to 2033 (USD Million)
- 4.6. Services
- 4.6.1. Services market estimates and forecasts 2021 to 2033 (USD Million)
- Chapter 5. Middle East Exosomes Market: Workflow Estimates & Trend Analysis
- 5.1. Workflow Segment Dashboard
- 5.2. Middle East Exosomes Market Workflow Movement Analysis
- 5.3. Middle East Exosomes Market Size & Trend Analysis, by Workflow, 2021 to 2033 (USD Million)
- 5.4. Isolation Methods
- 5.4.1. Isolation methods market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.2. Ultracentrifugation
- 5.4.2.1. Ultracentrifugation market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.3. Immunocapture on beads
- 5.4.3.1. Immunocapture on beads market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.4. Precipitation
- 5.4.4.1. Precipitation market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.5. Filtration
- 5.4.5.1. Filtration market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.6. Others
- 5.4.6.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
- 5.5. Downstream Analysis
- 5.5.1. Downstream analysis market estimates and forecasts 2021 to 2033 (USD Million)
- 5.5.2. Cell surface marker analysis using flow cytometry
- 5.5.2.1. Cell surface marker analysis using flow cytometry market estimates and forecasts 2021 to 2033 (USD Million)
- 5.5.3. Protein Analysis using blotting & ELISA
- 5.5.3.1. Protein Analysis using blotting & ELISA market estimates and forecasts 2021 to 2033 (USD Million)
- 5.5.4. RNA analysis with NGS & PCR
- 5.5.4.1. RNA analysis with NGS & PCR market estimates and forecasts 2021 to 2033 (USD Million)
- 5.5.5. Proteomic analysis using mass spectroscopy
- 5.5.5.1. Proteomic analysis using mass spectroscopy market estimates and forecasts 2021 to 2033 (USD Million)
- 5.5.6. Others
- 5.5.6.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
- Chapter 6. Middle East Exosomes Market: Application Estimates & Trend Analysis
- 6.1. Application Segment Dashboard
- 6.2. Middle East Exosomes Market Application Movement Analysis
- 6.3. Middle East Exosomes Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
- 6.4. Cancer
- 6.4.1. Cancer market estimates and forecasts 2021 to 2033 (USD Million)
- 6.5. Neurodegenerative Diseases
- 6.5.1. Neurodegenerative diseases market estimates and forecasts 2021 to 2033 (USD Million)
- 6.6. Cardiovascular Diseases
- 6.6.1. Cardiovascular diseases market estimates and forecasts 2021 to 2033 (USD Million)
- 6.7. Infectious Diseases
- 6.7.1. Infectious diseases market estimates and forecasts 2021 to 2033 (USD Million)
- 6.8. Others
- 6.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
- Chapter 7. Middle East Exosomes Market: End Use Estimates & Trend Analysis
- 7.1. End Use Segment Dashboard
- 7.2. Middle East Exosomes Market End Use Movement Analysis
- 7.3. Middle East Exosomes Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
- 7.4. Pharmaceutical & Biotechnology Companies
- 7.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5. Hospitals & Diagnostics Centers
- 7.5.1. Hospitals & diagnostics centers market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6. Academic & Research Institutes
- 7.6.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)
- Chapter 8. Middle East Exosomes Market: Regional Estimates & Trend Analysis
- 8.1. Regional Market Share Analysis, 2024 & 2033
- 8.2. Country Market Dashboard
- 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
- 8.4. Middle East
- 8.4.1. Middle East Exosomes Market, 2021 - 2033 (USD Million)
- 8.4.2. Saudi Arabia
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Competitive Scenario
- 8.4.2.3. Regulatory Framework
- 8.4.2.4. Saudi Arabia Exosomes Market, 2021 - 2033 (USD Million)
- 8.4.3. UAE
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Competitive Scenario
- 8.4.3.3. Regulatory Framework
- 8.4.3.4. UAE Exosomes Market, 2021 - 2033 (USD Million)
- 8.4.4. Kuwait
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. Competitive Scenario
- 8.4.4.3. Regulatory Framework
- 8.4.4.4. Kuwait Exosomes Market, 2021 - 2033 (USD Million)
- 8.4.5. Qatar
- 8.4.5.1. Key Country Dynamics
- 8.4.5.2. Competitive Scenario
- 8.4.5.3. Regulatory Framework
- 8.4.5.4. Qatar Exosomes Market, 2021 - 2033 (USD Million)
- 8.4.6. Oman
- 8.4.6.1. Key Country Dynamics
- 8.4.6.2. Competitive Scenario
- 8.4.6.3. Regulatory Framework
- 8.4.6.4. Oman Exosomes Market, 2021 - 2033 (USD Million)
- Chapter 9. Competitive Landscape
- 9.1. Company/Competition Categorization
- 9.2. Strategy Mapping
- 9.3. Company Market Position Analysis, 2024
- 9.4. Company Profiles/Listing
- 9.4.1. Bio-Techne Corporation
- 9.4.1.1. Company overview
- 9.4.1.2. Financial performance
- 9.4.1.3. Product/Service benchmarking
- 9.4.1.4. Strategic initiatives
- 9.4.2. Danaher
- 9.4.2.1. Company overview
- 9.4.2.2. Financial performance
- 9.4.2.3. Product/Service benchmarking
- 9.4.2.4. Strategic initiatives
- 9.4.3. Hologic Inc.
- 9.4.3.1. Company overview
- 9.4.3.2. Financial performance
- 9.4.3.3. Product/Service benchmarking
- 9.4.3.4. Strategic initiatives
- 9.4.4. Fujifilm Holdings Corporation
- 9.4.4.1. Company overview
- 9.4.4.2. Financial performance
- 9.4.4.3. Product/Service benchmarking
- 9.4.4.4. Strategic initiatives
- 9.4.5. Lonza
- 9.4.5.1. Company overview
- 9.4.5.2. Financial performance
- 9.4.5.3. Product/Service benchmarking
- 9.4.5.4. Strategic initiatives
- 9.4.6. Miltenyi Biotec
- 9.4.6.1. Company overview
- 9.4.6.2. Financial performance
- 9.4.6.3. Product/Service benchmarking
- 9.4.6.4. Strategic initiatives
- 9.4.7. QIAGEN
- 9.4.7.1. Company overview
- 9.4.7.2. Financial performance
- 9.4.7.3. Product/Service benchmarking
- 9.4.7.4. Strategic initiatives
- 9.4.8. Thermo Fisher Scientific, Inc.
- 9.4.8.1. Company overview
- 9.4.8.2. Financial performance
- 9.4.8.3. Product/Service benchmarking
- 9.4.8.4. Strategic initiatives
- 9.4.9. Abcam Plc
- 9.4.9.1. Company overview
- 9.4.9.2. Financial performance
- 9.4.9.3. Product/Service benchmarking
- 9.4.9.4. Strategic initiatives
- 9.4.10. RoosterBio, Inc.
- 9.4.10.1. Company overview
- 9.4.10.2. Financial performance
- 9.4.10.3. Product/Service benchmarking
- 9.4.10.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.